ArticlePediatric rheumatology online journal2018

Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study.

Yuzaburo Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.